SCHEMBL6632663

SCHEMBL6632663

Nc1ccc2c(ccn2S(=O)(=O)c2ccccc2)c1.O=[N+]([O-])c1ccc2c(ccn2S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 13/20 0.56
MEN1 O00255 2/20 0.51
HTT P42858 2/20 0.51
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 1/20 0.51
HDAC3 O15379 3/20 0.50
HDAC4 P56524 3/20 0.50
HDAC1 Q13547 3/20 0.50
HDAC7 Q8WUI4 3/20 0.50
HDAC2 Q92769 3/20 0.50
HDAC10 Q969S8 3/20 0.50
HDAC11 Q96DB2 3/20 0.50
HDAC8 Q9BY41 3/20 0.50
HDAC6 Q9UBN7 3/20 0.50
HDAC9 Q9UKV0 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2512172 0.93 HTR6 (0.62) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL2510832 0.87 HTR6 (0.68) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL29617199 0.87 HTR6 (0.68) HTR6MEN1HTTKMT2AALDH1A1
Hydroxyamine SCHEMBL14672692 0.85 HTR6 (0.65) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL20742991 0.82 HTR6 (0.62) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL13323640 0.81 HDAC3 (0.55) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL6236469 0.80 MET (0.52) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL29425682 0.78 HDAC1 (0.52) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL28692303 0.78 HDAC1 (0.52) HTR6MEN1HTTKMT2AALDH1A1
SCHEMBL1395018 0.78 HTR6 (0.69) HTR6MEN1HTTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444210-A1 QUNAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2004-08-11 EP disclosed
WO-2003040108-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2003-05-15 WO disclosed